Abdirashid M. Shire

1.4k total citations
26 papers, 1.0k citations indexed

About

Abdirashid M. Shire is a scholar working on Molecular Biology, Surgery and Epidemiology. According to data from OpenAlex, Abdirashid M. Shire has authored 26 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Surgery and 8 papers in Epidemiology. Recurrent topics in Abdirashid M. Shire's work include Fibroblast Growth Factor Research (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Proteoglycans and glycosaminoglycans research (4 papers). Abdirashid M. Shire is often cited by papers focused on Fibroblast Growth Factor Research (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Proteoglycans and glycosaminoglycans research (4 papers). Abdirashid M. Shire collaborates with scholars based in United States, United Kingdom and Bahrain. Abdirashid M. Shire's co-authors include Lewis R. Roberts, Dalbir S. Sandhu, Catherine D. Moser, Ileana Aderca, Jin-Ping Lai, Abdul M. Oseini, Schuyler O. Sanderson, Chunling Hu, Alex A. Adjei and Chunrong Yu and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Abdirashid M. Shire

24 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abdirashid M. Shire United States 16 537 227 220 170 161 26 1.0k
Huai‐Chia Chuang Taiwan 20 571 1.1× 50 0.2× 99 0.5× 130 0.8× 197 1.2× 38 1.1k
Anjian Xu China 18 547 1.0× 89 0.4× 83 0.4× 149 0.9× 173 1.1× 53 941
Nicholas Davies United Kingdom 15 584 1.1× 77 0.3× 191 0.9× 104 0.6× 298 1.9× 25 1000
Rachel A. Egler United States 14 397 0.7× 211 0.9× 65 0.3× 54 0.3× 152 0.9× 25 907
Carl Bart Rountree United States 17 569 1.1× 188 0.8× 79 0.4× 118 0.7× 359 2.2× 20 1.0k
Zsuzsa Schaff Hungary 18 300 0.6× 129 0.6× 91 0.4× 154 0.9× 181 1.1× 48 820
Amanda Micsenyi United States 16 824 1.5× 314 1.4× 95 0.4× 130 0.8× 219 1.4× 17 1.3k
Naoko Okayama Japan 20 643 1.2× 124 0.5× 70 0.3× 87 0.5× 403 2.5× 70 1.3k
Mengyi Wang China 20 449 0.8× 100 0.4× 166 0.8× 178 1.0× 275 1.7× 77 1.1k
Wesley R. Gage United States 12 726 1.4× 184 0.8× 36 0.2× 119 0.7× 228 1.4× 13 1.4k

Countries citing papers authored by Abdirashid M. Shire

Since Specialization
Citations

This map shows the geographic impact of Abdirashid M. Shire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdirashid M. Shire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdirashid M. Shire more than expected).

Fields of papers citing papers by Abdirashid M. Shire

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdirashid M. Shire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdirashid M. Shire. The network helps show where Abdirashid M. Shire may publish in the future.

Co-authorship network of co-authors of Abdirashid M. Shire

This figure shows the co-authorship network connecting the top 25 collaborators of Abdirashid M. Shire. A scholar is included among the top collaborators of Abdirashid M. Shire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdirashid M. Shire. Abdirashid M. Shire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pratt, Rebekah, et al.. (2019). Developing culturally informed genetic services for the Somali immigrants in Minnesota. Journal of Genetic Counseling. 28(4). 887–896. 11 indexed citations
3.
4.
Grossardt, Brandon R., et al.. (2013). Completion of the Human Papillomavirus Vaccination Series Lags in Somali Adolescents. Journal of Lower Genital Tract Disease. 17(3). 280–288. 18 indexed citations
5.
Shire, Abdirashid M. & Lewis R. Roberts. (2012). Prevention of hepatocellular carcinoma: progress and challenges.. PubMed. 58(1). 49–64. 8 indexed citations
6.
Shire, Abdirashid M., Dalbir S. Sandhu, Abdul M. Oseini, et al.. (2012). Viral Hepatitis Among Somali Immigrants in Minnesota: Association of Hepatitis C With Hepatocellular Carcinoma. Mayo Clinic Proceedings. 87(1). 17–24. 27 indexed citations
8.
Zheng, Xin, Natalia Belén Rumie Vittar, Xiaohong Gai, et al.. (2012). The Transcription Factor GLI1 Mediates TGFβ1 Driven EMT in Hepatocellular Carcinoma via a SNAI1-Dependent Mechanism. PLoS ONE. 7(11). e49581–e49581. 63 indexed citations
9.
Oseini, Abdul M., Roongruedee Chaiteerakij, Abdirashid M. Shire, et al.. (2011). Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology. 54(3). 940–948. 131 indexed citations
10.
Oseini, Abdul M., Catherine D. Moser, Chunrong Yu, et al.. (2010). The Oncogenic Effect of Sulfatase 2 in Human Hepatocellular Carcinoma Is Mediated in Part by Glypican 3–Dependent Wnt Activation. Hepatology. 52(5). 1680–1689. 93 indexed citations
11.
Lai, Jin-Ping, Dalbir S. Sandhu, Chunrong Yu, et al.. (2010). Sulfatase 2 protects hepatocellular carcinoma cells against apoptosis induced by the PI3K inhibitor LY294002 and ERK and JNK kinase inhibitors. Liver International. 30(10). 1522–1528. 26 indexed citations
12.
Sandhu, Dalbir S., Catherine D. Moser, Sophie C. Cazanave, et al.. (2009). Additive effect of apicidin and doxorubicin in sulfatase 1 expressing hepatocellular carcinoma in vitro and in vivo. Journal of Hepatology. 50(6). 1112–1121. 28 indexed citations
13.
Lai, Jin-Ping, Dalbir S. Sandhu, Abdirashid M. Shire, & Lewis R. Roberts. (2008). The Tumor Suppressor Function of Human Sulfatase 1 (SULF1) in Carcinogenesis. Journal of Gastrointestinal Cancer. 39(1-4). 149–158. 77 indexed citations
14.
Aderca, Ileana, Catherine D. Moser, Ahmad BaniHani, et al.. (2008). The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX. Journal of Hepatology. 49(3). 373–383. 43 indexed citations
15.
Lai, Jinping, Dalbir S. Sandhu, Chunrong Yu, et al.. (2008). Sulfatase 2 up‐regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma†. Hepatology. 47(4). 1211–1222. 168 indexed citations
16.
Shire, Abdirashid M., Hongzhi Zou, Ileana Aderca, et al.. (2008). BMP3 is hypermethylated and may function as a tumor suppressor in cholangiocarcinoma. 68. 4282–4282. 1 indexed citations
17.
Sandhu, Dalbir S., Abdirashid M. Shire, & Lewis R. Roberts. (2007). Epigenetic DNA hypermethylation in cholangiocarcinoma: potential roles in pathogenesis, diagnosis and identification of treatment targets. Liver International. 28(1). 12–27. 39 indexed citations
18.
Grassi, Michael A., John H. Fingert, Todd E. Scheetz, et al.. (2006). Ethnic variation in AMD-associated complement factor H polymorphism p.Tyr402His. Human Mutation. 27(9). 921–925. 56 indexed citations
19.
Shire, Abdirashid M. & J P Ackers. (2006). SINE elements of Entamoeba dispar. Molecular and Biochemical Parasitology. 152(1). 47–52. 8 indexed citations
20.
Ackers, J P, et al.. (2002). Differentiation of entamoeba histolytica/entamoeba dispar by PCR and their correlation with humoral and cellular immunity in individuals with clinical variants of amoebiasis.. American Journal of Tropical Medicine and Hygiene. 66(6). 731–737. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026